Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,707.60
Bid: 1,707.60
Ask: 1,707.80
Change: 2.40 (0.14%)
Spread: 0.20 (0.012%)
Open: 1,701.60
High: 1,709.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-EU mergers and takeovers (Dec 1)

Mon, 01st Dec 2014 21:53

(Corrects deadline for Chiquita takeover to Jan. 7 from Dec. 7)

BRUSSELS, Dec 1 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- U.S. medical device maker Medtronic Inc toacquire Irish peer Covidien (approved Nov. 28)

NEW LISTINGS

-- Swiss drugmaker Novartis to acquire Britishpeer GlaxoSmithKline's oncology products (notified Nov.28/deadline Jan. 14)

-- British drugmaker GlaxoSmithKline to acquireNovartis' vaccines business, excluding Flu, and thesettting up of a consumer healthcare joint venture (notifiedNov. 28/deadline Jan. 14)

-- Generic drugmaker Mylan Inc to purchase AbbotLaboratories' specialty and branded generics business outsidethe United States (notified Nov. 28/deadline Jan. 14)

-- PRS for Music Ltd (PRSfM), Foreningen Svenska TonsattaresInternationella Mysikbyra (Stim) and Gesellschaft fürmusikalische Aufführungs- und mechanischeVervielfältigungsrechte (Gema) to set up a joint venture toadminister mechanical and performing rights (notified Nov.28/deadline Jan. 14)

-- Czech energy group Energeticky a Prumyslovy Holding (EPH)to acquire the Eggborough British coal-fired power plant fromEggborough Power Ltd (notified Nov. 28/deadline Jan.14/simplified)

-- Private equity firm CVC Capital Partners toacquire Dutch cable and wires producer Betafence Holding NV(notified Nov. 28/deadline Jan. 14/simplified)

-- Wood products retailer Oji Holdings andpetroleum products retailer Itochu Enex Co. Ltd to setup two joint ventures in Japan (notified Nov. 27/deadline Jan.13/simplified)

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

DEC 1

-- Mondelez International Inc and competitor D.EMaster Blenders to merge their coffee businesses innew company called Jacobs Douwe Egberts (notified Oct.27/deadline Dec. 1)

-- Oil major BP to acquire jet fuel business StatoilFuel and Retail Aviation (notified Oct. 27/deadline Dec. 1)

DEC 4

-- French telecoms operator Orange to acquireSpanish provider Jazztel (notified Oct. 16/deadlineextended to Dec. 4 from Nov. 20 after the Spanish competitionauthority asked to review the case/commitments submitted on Nov.13)

DEC 5

-- Malaysian palm oil producer Sime Darby Bhd toacquire New Britain Palm Oil Ltd (notified Oct.31/deadline Dec. 5/simplified

DEC 9

-- U.S. healthcare information company IMS Health toacquire certain businesses from French healthcare softwareprovider Cegedim (notified Nov. 4/deadline Dec. 9)

DEC 10

-- Santander Consumer Finance, part of Spanish bankSantander, and French car maker Peugeot S.A. (PSA) toset up a series of joint finance companies (notified Nov.5/deadline Dec. 10)

DEC 11

-- Mining groups Anglo American and BHP Billiton to acquire joint control of manganese minerSamancor which is now solely controlled by BHP Billiton(notified Nov. 6/deadline Dec. 11/simplified)

-- Oil giant Saudi Aramco to buy a minority stake in SouthKorean refiner S-Oil Corp from Hanjin Group (notified Nov. 6/deadline Dec. 11/simplified)

DEC 12

-- U.S. investment management firm Varder Partners toacquire 51 percent of Spanish bank Popular's creditcard business (notified Nov. 14/deadline Dec. 12/simplified)

-- Privately-held Czech airline Travel Service to take a 34percent stake in national carrier Czech Airlines (notified Nov.14/deadline Dec. 12

DEC 15

-- Oil major BP to acquire jet fuel business StatoilFuel and Retail Aviation (notified Oct. 27/deadline extended toDec. 15 from Dec. 1 after the companies offered concessions)

-- Mondelez International Inc and competitor D.EMaster Blenders to merge their coffee businesses innew company called Jacobs Douwe Egberts (notified Oct.27/deadline extended to Dec. 15 from Dec. 1 after the companiesoffered concessions)

-- Aerospace group Airbus and Singapore Airlines to jointly acquire Airbus Asia Training Centre(notified Nov. 10/deadline Dec. 15/simplified)

-- France's Lafarge and Swiss peer Holcim to merge (notified with commitments on Oct.27/deadline Dec. 15)

DEC 16

-- Private equity firms Blackstone and TPG to jointlyacquire British mortgage lender Kensington Group plc (notifiedNov. 11/deadline Dec. 16/simplified)

DEC 17

-- Private equity firm 3i to acquire Diamond Holding GmbHfrom German jewellery retailer Group Christ Juweliere undUnrmacher Seit (notified Nov. 12/deadline Dec. 17/simplified)

DEC 18

-- ReAssure to acquire HSBC's pensionsmanufacturing business (notified Nov. 13/deadline Dec.18/simplified)

DEC 19

-- Private equity firm CCMP Capital to acquire joint controlof chemicals producer PQ Holdings Inc which is now jointlycontrolled by INEOS and private equity group The Carlyle GroupLP (notified Nov. 14/deadline Dec. 19/simplified)

-- Czech state-owned holding company Cesky Aeroholding andprivately-owned low-cost Czech carrier Travel Service to jointlyacquire Czech Airlines (notified Nov. 14/deadline Dec. 19)

-- Private equity firm EQT to acquire German engineeringgroups Siemens's hearing-aids business (notified Nov.14/deadline Dec. 19/simplified)

-- CCMP Capital to acquire 47 percent stake in PQ Corp fromCarlyle Group (notified Nov. 14/deadline Dec.19/simplified)

-- Yanfeng Automotive Trim Systems, a subsidiary of China'sbiggest automaker SAIC Motor Corp., to acquire Johnson Control's auto interiors business (notified Nov. 14/deadline Dec.19/simplified)

DEC 23

-- U.S. company IBM to take over German airlineLufthansa's information technology infrastructureservices division and staff for 1 billion euros (notified Nov.18/deadline Dec. 23)

JAN 5

-- Norwegian telecoms firm Telenor to form a jointventure with media company Schibsted, South Africa'sNaspers and Singapore Press Holdings (notified Nov. 19/deadline Jan. 5/simplified)

JAN 6

-- French holding company Eurazeo and GroupeCredit Agricole to jointly acquire two buildingcomplexes SCI Lafayette and SCI Stratege (notified Nov.20/deadline Jan. 6/simplified)

-- Hong Kong conglomerate Cheung Kong to formjoint venture with Mitsubishi Corp's leasing arm MCAviation Partners (notified Nov. 20/deadline Jan. 6/simplified)

JAN 7

-- Brazilian juice maker Grupo Cutrale and investment firmSafra Group to jointly acquire U.S. banana producer Chiquita (notified Nov. 21/deadline Jan. 7/simplified)

JAN 8

-- Dutch investment firm SHV to acquire Dutch animal feedand nutrition company Nutreco (notified Nov.24/deadline Jan. 8/simplified)

-- Norwegian media group Schibsted and Norwegiantelecoms operator Telenor to set up a jointventure(notified Nov. 25/deadline Jan. 8/simplified)

-- Investment firm Apollo Management to acquire Italianinsurer Carige (notified Nov. 24/deadline Jan. 8/simplified)

FEB 5

-- Belgian telecoms group Telenet to acquire 50percent stake in Belgian broadcasting company De Vijver Media(notified Aug. 18/deadline extended for the second time to March5 from Feb. 5)

MARCH 5

-- Belgian telecoms group Telenet, which is asubsidiary of U.S. cable group Liberty Global, toacquire 50 percent stake in Belgian broadcasting company DeVijver Media (notified Aug. 18/deadline extended for the secondtime to March 5 from Feb. 5/companies submitted concessions onNov. 24)

MARCH 18

-- U.S. orthopaedic products maker Zimmer Holdings to acquire rival Biomet Inc (notified Aug.29/deadline extended for the third time to March 18 from March11)

APRIL 22

-- SOCAR, Azerbaijan's state energy company, to buy stakesin Greek natural gas grid operator DESFA from Greek natural gasutility DEPA (notified Oct. 1/deadline extended for the secondtime to April 22 from March 23)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified -- that is, ordinary first-stage reviews -- untilthey are approved. (Editing by Foo Yun Chee)

More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.